Overall, DEN induced the upregulation of 190, 260 and 1109 genes and the downregulation of 325, 570 and 929 genes in primary AML, OCI-AML3 and TPH-1 cells, respectively (Figure 4A). The gene discussed is RUNX2; the disease is acute myeloid leukemia.